Editorial - World Kidney day 2018 What we know and do not know about kidney diseases in women; unanswered questions and answers to unasked questions: reflections on World Kidney Day and International Women's Day

  • Authors: Piccoli G.B1, Mona A.2, Zhi-Hong L.3,4, Zakharova E.V5,6,7, Adeera L.8
  • Affiliations:
    1. University of Torino
    2. Dubai Medical College
    3. National Center for Clinical Studies of Kidney Diseases, Gingling Hospital
    4. Nanjing University School of Medicine
    5. City Clinical Hospital n.a. S.P. Botkin
    6. Moscow State Medical Stomatological University n.a. A.i. Evdokimov
    7. Russian Medical Academy of Continuous Postgraduate Education
    8. University of British Columbia
  • Issue: No 1 (2018)
  • Pages: 8-19
  • Section: Articles
  • URL: https://journals.eco-vector.com/2075-3594/article/view/272750
  • ID: 272750

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Full Text

Restricted Access

About the authors

G. B Piccoli

University of Torino

Department of Clinical and Biological Sciences, Department of Nephrology Italy; Le Mans, France

Alrukhami Mona

Dubai Medical College

Department of Medicine, Dubai Medical College Dubai, United Arab Emirates

Liu Zhi-Hong

National Center for Clinical Studies of Kidney Diseases, Gingling Hospital; Nanjing University School of Medicine

Nanjing, China

E. V Zakharova

City Clinical Hospital n.a. S.P. Botkin; Moscow State Medical Stomatological University n.a. A.i. Evdokimov; Russian Medical Academy of Continuous Postgraduate Education

Department of Nephrology, Department of Nephrology, Department of Nephrology, Moscow, Russia

Levin Adeera

University of British Columbia

Division of Medicine, Department of Nephrology British Columbia, Canada

References

  1. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388(10053):1545-1602. doi: 10.1016/S0140-6736(16)31678-6.
  2. Von Dadelszen P., Payne B., Li J. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of 'the full PIERS model. Lancet. 2011; 377(9761):219-227. doi: 10.1016/S0140-6736(10)61351-7.
  3. Mol B.W.J., Roberts C.T., Thangaratinam S., Magee L.A. Pre-eclampsia. Lancet. 2016; 387(10022):999-1011. doi: 10.1016/S0140-6736(15)00070-7.
  4. Vikse B.E., Irgens L.M., Leivestad T. Preeclampsia and the risk of end-stage renal disease. N. Engl. J. Med. 2008;359(8):800-809. doi: 10.1056/NEJMoa0706790.
  5. Theilen L.H., Fraser A., Hollingshaus M.S. et al. All-Cause and Cause-Specific Mortality After Hypertensive Disease of Pregnancy. Obstet Gynecol. 2016;128(2):238-244.
  6. Piccoli G.B., Cabiddu G., Attini R. et al. Risk of Adverse Pregnancy Outcomes in Women with CKD. J Am Soc Nephrol 2015;26(8):2011-2022. Doi: 10.1681/ ASN.2014050459.
  7. Zhang J.-J., Ma X.-X., Hao L., et al. A systematic review and meta-analysis of outcomes of pregnancy in CKD and CKD outcomes in pregnancy. Clin. J. Am. Soc. Nephrol. 2015;10(11):1964-1978. doi: 10.2215/CJN.09250914.
  8. Alkhunaizi A., Melamed N., Hladunewich M.A. Pregnancy in advanced chronic kidney disease and end-stage renal disease. Curr. Opin. Nephrol. Hypertens. 2015;24(3):252-259. doi: 10.1097/MNH.0000000000000119.
  9. Piccoli G.B., Cabiddu G., Castellino S., et al. A best practice position statement on the role of the nephrologist in the prevention and follow-up of preeclampsia: the Italian study group on kidney and pregnancy. J. Nephrol. 2017;30(3):307-317. doi: 10.1007/s40620-017-0390-1.
  10. Liu Y., Ma X., Zheng J., Liu X., Yan T. Pregnancy outcomes in patients with acute kidney injury during pregnancy: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2017;17(1):235. doi: 10.1186/s12884-017-1402-9.
  11. Jim B., Garovic V.D. Acute kidney injury in pregnancy. Semin. Nephrol. 2017;37(4):378-385. doi: 10.1016/j.semnephrol.2017.05.010.
  12. Acharya A. Management of acute kidney injury in pregnancy for the obstetrician. Obstet. Gynecol. Clin. North. Am. 2016;43(4):747-765. Doi: 10.1016/j. ogc.2016.07.007.
  13. Iseki K. Gender differences in chronic kidney disease. Kidney International. 2008;74(4):415-417. doi: 10.1038/ki.2008.261.
  14. Nitsch D., Grams M., Sang Y., et al. Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis. BMJ. 2013;346:f324. doi: 10.1136/bmj.f324.
  15. Levin A., Djurdjev O., Beaulieu M., Er L. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort. Am. J. Kidney Dis. 2008;52(4):661-671. Doi: 10.1053/j. ajkd.2008.06.023.
  16. Weiner D.E., Tighiouart H., Elsayed E.F., et al. The Framingham predictive instrument in chronic kidney disease. J. Am. Coll. Cardiol. 2007;50(3):217-224. doi: 10.1016/j.jacc.2007.03.037.
  17. Oladapo O.T., Adetoro O.O., Ekele B.A., et al. When getting there is not enough: a nationwide cross-sectional study of 998 maternal deaths and 1451 near-misses in public tertiary hospitals in a low-income country. BJOG. 2016;123(6):928-938. doi: 10.1111/1471-0528.13450.
  18. Tranquilli A.L., Dekker G., Magee L., et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP. Pregnancy Hypertens. 2014;4(2):97-104. Doi: 10.1016/j. preghy.2014.02.001.
  19. Liu Y., Bao H., Jiang Z., et al. Pregnancy-related Acute kidney injury and a review of the literature in China. Intern. Med. 2015;54(14):1695-1703. Doi: 10.2169/ internalmedicine.54.3870.
  20. Prakash J., Pant P., Prakash S., et al. Changing picture of acute kidney injury in pregnancy: Study of 259 cases over a period of 33 years. Indian J. Nephrol. 2016;26(4):262-267. doi: 10.4103/0971-4065.161018.
  21. Ibarra-Hernández M., Orozco-Guillén O.A., de la Alcantar-Vallín M.L., et al. Acute kidney injury in pregnancy and the role of underlying CKD: a point of view from México. J. Nephrol. 2017;30(6):773-780. doi: 10.1007/s40620-017-0444-
  22. Blázquez A., García D., Rodríguez A., et al. Is oocyte donation a risk factor for preeclampsia? A systematic review and meta-analysis. J. Assist. Reprod. Genet. 2016;33(7):855-863. doi: 10.1007/s10815-016-0701-9.
  23. O’Gorman N., Wright D., Poon L.C., et al. Multicenter screeningfor pre-eclampsia by maternal factors and biomarkers at 11-13 weeks’ gestation: comparison with NICE guidelines and ACOG recommendations. Ultrasound Obstet. Gynecol. 2017;49(6):756-760. doi: 10.1002/uog.17455.
  24. Zeisler H., Llurba E., Chantraine F., et al. Predictive value of the sFlt-1:PlGFratio in women with suspected preeclampsia. N. Engl. J. Med. 2016;374(1):13-22. doi: 10.1056/NEJMoa1414838.
  25. Garovic V.D. The role of the podocyte in preeclampsia. Clin. J. Am. Soc. Nephrol. 2014;9(8):1337-1340. doi: 10.2215/CJN.05940614.
  26. Wide-Swensson D., Strevens H., Willner J. Antepartum percutaneous renal biopsy. Int. J. Gynaecol Obstet. 2007;98(2):88-92. doi: 10.1016/j.ijgo.2007.03.049.
  27. Shiiki H., Dohi K., Hanatani M., et al. Focal and segmental glomerulosclerosis in preeclamptic patients with nephrotic syndrome. Am. J. Nephrol. 1990;10(3):205-212. PMID: 2382682.
  28. Linsell L., Malouf R., Morris J., et al. Risk factor models for neurodevelopmental outcomes in children born very preterm or with very low birth weight: a systematic review of methodology and reporting. Am. J. Epidemiol. 2017;185(7):601-612.
  29. Guellec I., Lapillonne A., Marret S., et al. Effect of intra- and extrauterine growth on long-term neurologic outcomes of very preterm Infants. J. Pediatr. 2016;175:93-99.e1. doi: 10.1016/j.jpeds.2016.05.027.
  30. Moore T., Hennessy E.M., Myles J., et al. Neurological and developmental outcome in extremely preterm children born in England in 1995 and 2006: the EPICurestudies. BMJ. 2012;345:e7961. doi: 10.1136/bmj.e7961.
  31. Guillén Ú., DeMauro S., Ma L., et al. Relationship between attrition and Neurodevelopmental Impairment Rates in Extremely Preterm Infants at 18 to 24 Months: a systematic review. Arch. Pediatr. Adolesc. Med. 2012;166(2):178-184. doi: 10.1001/archpediatrics.2011.616.
  32. Ranke M.B., Schweizer R., Rodemann S.M., et al. Schoolchildren born VLBW or VLGA show height-related changes in body composition and musclefunction but no evidence of metabolic syndrome risk factors. Results from the NEOLONG study. J. Pediatr. Endocrinol. Metab. 2016;29(2):163-172. doi: 10.1515/jpem-2015-0266.
  33. Castanys-Muñoz E., Kennedy K., Castañeda-Gutiérrez E., et al. Systematic review indicates postnatal growth in term infants born small-for-gestational-age being associated with later neurocognitive and metabolic outcomes. Acta. Paediatr. 2017;106(8):1230-1238. doi: 10.1111/apa.13868.
  34. Ong K.K., Kennedy K., Castañeda-Gutiérrez E., et al. Postnatal growth in preterm infants and later health outcomes: a systematic review. Acta. Paediatr. 2015;104(10):974-986. doi: 10.1111/apa.13128.
  35. Low birth weight and nephron number working group. The impact of kidney development on the life course: a consensus document for action. Nephron. 2017;136(1):3-49. doi: 10.1159/000457967.
  36. Luyckx V.A., Bertram J.F., Brenner B.M., et al. Effect of fetal and child health on kidney development and long-term risk of hypertension and kidney disease. Lancet. 2013;382(9888):273-283. doi: 10.1016/S0140-6736(13)60311-6.
  37. Luyckx V.A., Brenner B.M. Birth weight, malnutrition and kidney-associated outcomes a global concern. Nat. Rev. Nephrol. 2015;11(3):135-149. doi: 10.1038/nrneph.2014.251.
  38. Davison J.M., Lindheimer M.D. Pregnancy and chronic kidney disease. Semin. Nephrol. 2011;31(1):86-99. doi: 10.1016/j.semnephrol.2010.10.008.
  39. Hall M. Pregnancy in women with CKD: a success story. Am. J. Kidney Dis. 2016;68(4):633-639. doi: 10.1053/j.ajkd.2016.04.022.
  40. Nevis I.F., Reitsma A., Dominic A. et al. Pregnancy outcomes in women with chronic kidney disease: a systematic review. Clin. J. Am. Soc. Nephrol. 201;6(11):2587-2598. doi: 10.2215/CJN.10841210.
  41. Cabiddu G., Castellino S., Gernone G., et al. A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy. J. Nephrol. 2016;29(3):277-303. doi: 10.1007/s40620-016-0285-6.
  42. Garg A.X., Nevis I.F., McArthur E., et al. Gestational hypertension and preeclampsia in living kidney donors. N. Engl. J. Med. 2015;372(2):124-133. doi: 10.1056/NEJMoa1408932.
  43. Josephson M.A. Transplantation: pregnancy after kidney donation: more questions than answers. Nat. Rev. Nephrol. 2009;5(9):495-497. Doi: 10.1038/ nrneph.2009.129.
  44. Gianfreda D., Quaglini S., Frontini G., et al. Does pregnancy have any impact on long term damage accrual and on the outcome of lupus nephritis? J. Autoimmun. 2017;84:46-54. doi: 10.1016/j.jaut.2017.06.003.
  45. Blom K., Odutayo A., Bramham K., Hladunewich M.A. Pregnancy and glomerular disease: a systematic review of the literature with management guidelines. Clin. J. Am. Soc. Nephrol. 2017;12(11):1862-1872. doi: 10.2215/CJN.00130117.
  46. Imbasciati E., Gregorini G., Cabiddu G., et al. Pregnancy in CKD stages 3 to 5: fetal and maternal outcomes. Am. J. Kidney. Dis. 2007;49(6):753-762. doi: 10.1053/j.ajkd.2007.03.022.
  47. Fischer M.J. Chronic kidney disease and pregnancy: maternal and fetal outcomes. Adv. Chronic. Kidney Dis. 2007;14(2):132-145. Doi: 10.1053/j. ackd.2007.01.004.
  48. Bramham K. Diabetic nephropathy and pregnancy. Semin. Nephrol. клиническая нефрология №1 - 2018 2017;37(4):362-369. doi: 10.1016/j.semnephrol.2017.05.008.
  49. Eswarappa M., Rakesh M., Sonika P., et al. Spectrum of renal injury in pregnancy-induced hypertension: Experience from a single center in India. Saudi Journal of Kidney Diseases and Transplantation. 2017;28(2):279. doi: 10.4103/1319-2442.202790.
  50. Prakash J. The kidney in pregnancy: A journey of three decades. Indian. J. Nephrol. 2012;22(3):159-167. doi: 10.4103/0971-4065.98750.
  51. Piccoli G.B., Fassio F., Attini R., et al. Pregnancy in CKD: whom should we follow and why? Nephrol. Dial. Transplant. 2012;27(3):iii111-118. doi: 10.1093/ndt/ gfs302.
  52. Piccoli G.B., Cabiddu G., Daidone G., et al. The children of dialysis: liveborn babies from on-dialysis mothers in Italy - an epidemiological perspective comparing dialysis, kidney transplantation and the overall population. Nephrol. Dial. Transplant. 2014;29(8):1578-1586. doi: 10.1093/ndt/gfu092.
  53. Jesudason S., Grace B.S., McDonald S.P. Pregnancy outcomes according to dialysis commencing before or after conception in women with ESRD. Clin. J. Am. Soc. Nephrol 2014;9(1):143-149. doi: 10.2215/CJN.03560413.
  54. Hladunewich M.A., Hou S., Odutayo A., et al. Intensive hemodialysis associates with improved pregnancy outcomes: a Canadian and United States cohort comparison. J. Am. Soc. Nephrol. 2014;25(5):1103-1109. Doi:10.1681/ ASN.2013080825.
  55. Piccoli G.B., Minelli F., Versino E., et al. Pregnancy in dialysis patients in the new millennium: a systematic review and meta-regression analysis correlating dialysis schedules and pregnancy outcomes. Nephrol. Dial. Transplant. 2016;31(11):1915- 1934. doi: 10.1093/ndt/gfv395.
  56. Deshpande N.A., James N.T., Kucirka L.M., et al. Pregnancy outcomes in kidney transplant recipients: a systematic review and meta-analysis. Am. J. Transplant. 2011;11(11):2388-2404. doi: 10.1111/j.1600-6143.2011.03656.x.
  57. Deshpande N.A., Coscia L.A., Gomez-Lobo V., et al. Pregnancy after solid organ transplantation: a guide for obstetric management. Rev. Obstet. Gynecol. 2013;6(3-4):116-125. PMC4002187.
  58. Bramham K., Nelson-Piercy C., Gao H., et al. Pregnancy in renal transplant recipients: a UK national cohort study. Clin. J. Am. Soc. Nephrol. 2013;8(2):290- 298. doi: 10.2215/CJN.06170612.
  59. Piccoli G.B., Cabiddu G., Attini R., et al. Outcomes of pregnancies after kidney transplantation: lessons learned from CKD. A comparison of transplanted, nontransplanted chronic kidney disease patients and low-risk pregnancies: a multicenter nationwide analysis. Transplantation. 2017;101(10):2536-2544. doi: 10.1097/TP.0000000000001649.
  60. Webster P., Lightstone L., McKay D.B., Josephson M.A. Pregnancy in chronic kidney disease and kidney transplantation. Kidney Int. 2017; 91(5):1047-1056. doi: 10.1016/j.kint.2016.10.045.
  61. Pietrzak B., Mazanowska N., Kociszewska-Najman B., et al. Successful pregnancy outcome after in vitro fertilization in a kidney graft recipient: a case report and literature review. Ann. Transplant. 2015;20:338-341. Doi: 10.12659/ AOT.893735.
  62. Norrman E., Bergh C., Wennerholm U-B. Pregnancy outcome and long-term follow-up after in vitro fertilization in women with renal transplantation. Hum. Reprod. 2015;30(1):205-213. doi: 10.1093/humrep/deu293.
  63. Tedeschi S.K., Bermas B., Costenbader K.H. Sexual disparities in the incidence and course of SLE and RA. Clin. Immunol. 2013;149(2):211-218. Doi: 10.1016/j. clim.2013.03.003.
  64. Marder W., Vinet É., Somers E.C. Rheumatic autoimmune diseases in women and midlife health. Womens Midlife Health. 2015[cited 2017 Oct 19];1. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444314/.
  65. Ortona E., Pierdominici M., Maselli A., et al. Sex-based differences in autoimmune diseases. Ann. Ist. Super Sanita. 2016;52(2):205-212. Doi: 10.4415/ ANN_16_02_12.
  66. Petri M. Epidemiology of systemic lupus erythematosus. Best. Pract. Res. Clin. Rheumatol. 2002;16(5):847-858. PMID: 12473278.
  67. Weckerle C.E., Niewold T.B. The unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies. Clin. Rev. Allergy. Immunol. 2011;40(1):42-49. doi: 10.1007/s12016-009-8192-4.
  68. Scofield R.H., Bruner G.R., Namjou B., et al. Klinefelter’s syndrome (47,XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome. Arthritis Rheum. 2008;58(8):2511-2517. doi: 10.1002/art.23701.
  69. Pierdominici M., Ortona E. Estrogen impact on autoimmunity onset and progression: the paradigm of systemic lupus erythematosus. Int. Trends in Immun. 2013;1(2):24-34.
  70. Maselli A., Conti F., Alessandri C., et al. Low expression of estrogen receptor ß in T lymphocytes and high serum levels of anti-estrogen receptor a antibodies impact disease activity in female patients with systemic lupus erythematosus. Biol. Sex. Differ. 2016 [cited 2017 Oct 19];7. Available from: https://www.ncbi.nlm.nih.gov/ pmc/articles/PMC4709986/
  71. Kim S.J., Schätzle S., Ahmed S.S., et al. Increased cathepsin S in Prdm1(-/-) dendritic cells alters the TFH cell repertoire and contributes to lupus. Nat. Immunol. 2017;18(9):1016-1024. doi: 10.1038/ni.3793.
  72. Langefeld C.D., Ainsworth H.C., Cunninghame Graham D.S., et al. Transancestral mapping and genetic load in systemic lupus erythematosus. Nat. Commun. 2017;8:16021. doi: 10.1038/ncomms16021.
  73. Niewold T.B., Hua J., Lehman T.J.A., et al. High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus. Genes. Immun. 2007;8(6):492-502. doi: 10.1038/sj.gene.6364408.
  74. Tower C., Mathen S., Crocker I., Bruce I.N. Regulatory T cells in systemic lupus erythematosus and pregnancy. Am. J. Reprod. Immunol. 2013;69(6):588-595. doi: 10.1111/aji.12081.
  75. Almaani S., Meara A., Rovin B.H. Update on lupus nephritis. CJASN. 2016;CJN.05780616. doi: 10.2215/CJN.05780616.
  76. Buyon J.P., Kim M.Y., Guerra M.M., et al. Kidney outcomes and risk factors for nephritis (Flare/De Novo) in a multiethnic cohort of pregnant patients with lupus. Clin. J. Am. Soc. Nephrol. 2017;12(6):940-946. doi: 10.2215/CJN.11431116.
  77. Yelin E., Yazdany J., Trupin L. Relationship between process of care and a subsequent increase in damage in systemic lupus erythematosus. Arthritis Care & Research. 2017;69(6):927-932. doi: 10.1002/acr.22977.
  78. Kaplowitz E.T., Ferguson S., Guerra M., et al. Socioeconomic status contributes to racial/ethnic disparities in adverse pregnancy outcomes among women with systemic lupus erythematosus. Arthritis Care Res. 2017;69(6):833-841. doi: 10.1002/acr.23021.
  79. Myasoedova E., Crowson C.S., Kremers H.M. et al. Is the incidence of rheumatoid arthritis rising? Results from Olmsted County, Minnesota, 1955-2007. Arthritis Rheum. 2010;62(6):1576-1582. doi: 10.1002/art.27425.
  80. Goemaere S., Ackerman C., Goethals K., et al. Onset of symptoms of rheumatoid arthritis in relation to age, sex and menopausal transition. J. Rheumatol. 1990;17(12):1620-1622 PMID: 2084234.
  81. De Man Y.A., Dolhain R.J., van de Geijn F.E., et al. Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis. Rheum. 2008;59(9):1241-1248.
  82. Icardi A., Araghi P., Ciabattoni M., et al. Kidney involvement in rheumatoid arthritis. Reumatismo. 2003;55(2):76-85. PMID: 12874640.
  83. Anders H.-J., Vielhauer V. Renal comorbidity in patients with rheumatic diseases. Arthritis. Research & Therapy. 201;13:222. doi: 10.1186/ar3256.
  84. Chiu H.-Y., Huang H.-L., Li C.-H., et al. Increased risk of chronic kidney disease in Rheumatoid Arthritis Associated with Cardiovascular Complications - A National Population-Based Cohort Study. PLOS ONE. 2015;10(9):e0136508. doi: 10.1371/journal.pone.0153431.
  85. Vinet É., Bernatsky S., Hudson M., et al. Effect of menopause on the modified Rodnan skin score in systemic sclerosis. Arthritis Research & Therapy. 2014;16:R130. doi: 10.1186/ar4587.
  86. Sammaritano L.R. Menopause in patients with autoimmune diseases. Autoimmun Rev. 2012;11(6-7):A430-436. doi: 10.1016/j.autrev.2011.11.006.
  87. Penn H., Denton C.P. Diagnosis, management and prevention of scleroderma renal disease. Curr. Opin. Rheumatol. 2008;20(6):692-696. Doi: 10.1097/ BOR.0b013e3283108df7.
  88. Anders H.J., Wiebecke B., Haedecke C., et al. MPO-ANCA-Positive crescentic glomerulonephritis: a distinct entity of scleroderma renal disease? Am. J. Kidney Dis. 1999;33(4):e3. PMID: 10196034.
  89. Zakharova E.V., Makarova T.A., Stolyarevich E.S. ANCA-Associated Vasculitis in Patient with CREST-Syndrome - Case Report [Internet]. [cited 2017 Oct 19]. Available from: https://www.peertechz.com/Clinical-Nephrology/ACN-2-115. php.
  90. Eckardt K-U., Coresh J., Devuyst O., et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet. 2013;382(9887):158-169. doi: 10.1016/S0140-6736(13)60439-0.
  91. Saran R., Robinson B., Abbott K.C. et al. US renal data system 2016 annual data report: epidemiology of kidney disease in the United States. Am. J. Kidney Dis. 2017;69(3,1):A7-8. doi: 10.1053/j.ajkd.2016.12.004.
  92. Liyanage T., Ninomiya T., Jha V., et al. Worldwide access to treatment for endstage kidney disease: a systematic review. Lancet. 2015;385(9981):1975-1982. doi: 10.1016/S0140-6736(14)61601-9.
  93. Ojo A. Addressing the global burden of chronic kidney disease through clinical and translational research. Trans. Am. Clin. Climatol. Assoc. 2014;125:229-243; discussion 243-246.
  94. WHO. Addressing gender within primary health care reforms. In: WHO editor. Gender, women and primary health care renewal: a discussion paper [Internet]. [cited 2017 Oct 19]. Available from: http://apps.who.int/iris/bitstre am/10665/44430/1/9789241564038_eng.pdf.
  95. Eguavoen A.N.T., Odiagbe S.O., Obetoh G.I. The status of women, sex preference, decision-making and fertility control in ekpoma community of Nigeria. J. Soc. Sci. 2007;15(1):43-49.
  96. Halle M.P., Takongue C., Kengne A.P., et al. Epidemiological profile of patients with end stage renal disease in a referral hospital in Cameroon. BMC Nephrol. 2015;16:59. doi: 10.1186/s12882-015-0044-2.
  97. Ajayi S., Raji Y., Bello T., et al. Unaffordability of renal replacement therapy in Nigeria. Hong Kong Journal of Nephrology 2016;18:15-29.
  98. Kausz A.T., Obrador G.T., Arora P., et al. Late initiation of dialysis among women and ethnic minorities in the United States. J. Am. Soc. Nephrol. 2000;11(12):2351-2357. PMID: 11095658.
  99. Coresh J., Byrd-Holt D., Astor B.C., et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J. Am. Soc. Nephrol. 2005;16(1):180-188. doi: 10.1681/ASN.2004070539.
  100. Adams S.V., Rivara M., Streja E., et al. Sex differences in hospitalizations with maintenance hemodialysis. J. Am. Soc. Nephrol. 2017;28(9):2721-2728. doi: 10.1681/ASN.2016090986.
  101. Ethier J., Mendelssohn D.C., Elder S.J., et al. Vascular access use and outcomes: an international perspective from the Dialysis Outcomes and Practice Patterns Study. Nephrol. Dial. Transplant. 2008;23(10):3219-3226. doi: 10.1093/ndt/ gfn261.
  102. Depner T.A. Prescribing hemodialysis: the role of gender. Adv. Ren. Replace Ther. 2003;10(1):71-77. doi: 10.1053/jarr.2003.50007.
  103. Sehgal A.R. Outcomes of renal replacement therapy among blacks and women. Am. J. Kidney Dis. 2000;35(4):S148-152. PMID: 10766013.
  104. Jindal R.M., Ryan J.J., Sajjad I., et al. Kidney transplantation and gender disparity. Am. J. Nephrol. 2005;25(5):474-483. doi: 10.1159/000087920.
  105. Couchoud C., Bayat S., Villar E., et al. REIN registry. A new approach for measuring gender disparity in access to renal transplantation waiting lists. Transplantation. 2012; 94(5):513-519.
  106. Liu G., Li X., Liu T., et al. Gender disparity of living donor renal transplantation in East China. Clin. Transplant. 2013;27(1):98-103. doi: 10.1111/ctr.12003.
  107. Naghibi O., Naghibi M., Nazemian F. Gender disparity in kidney transplantation
  108. Piccoli G.B., Attini R., Cabiddu G., et al. Maternal-fetal outcomes in pregnant women with glomerulonephritides. Are all glomerulonephritides alike in pregnancy? J. Autoimmun. 2017;79:91-98. doi: 10.1016/j.jaut.2017.01.008.
  109. Seeger H., Salfeld P., Eisel R., et al. Complicated pregnancies in inherited distal renal tubular acidosis: importance of acid-base balance. J. Nephrol. 2017;30(3):455-460. doi: 10.1007/s40620-016-0370-x.
  110. Yefet E., Tovbin D., Nachum Z. Pregnancy outcomes in patients with Alport syndrome. Arch. Gynecol. Obstet. 2016;293(4):739-747. doi: 10.1007/s00404-015-3893-9. Поступила 10.01.2018 Принята в печать 08.02.2018 Received 10.01.2018 Accepted 08.02.2018 Saudi. J. Kidney Dis. Transpl. 2008;19(4):545-550. PMID: 18580010.
  111. Bal M.M., Saikia B. Gender bias in renal transplantation: are women alone donating kidneys in India? Transplant. Proc. 2007;39(10):2961-2963. doi: 10.1016/j.transproceed.2007.08.089.
  112. Hogan J, Couchoud C., Bonthuis M., et al. Gender disparities in access to pediatric renal transplantation in Europe: datafrom the ESPN/ERA-EDTA Registry. Am. J. Transplant. 2016;16(7):2097-2105. doi: 10.1111/ajt.13723.
  113. Gillespie A., Hammer H., Kolenikov S., et al. Sex differences and attitudes toward living donor kidney transplantation among urban black patients on hemodialysis. Clin. J. Am. Soc. Nephrol. 2014;9(10):1764-1772. doi: 10.2215/CJN.12531213.
  114. Salter M.L., McAdams-Demarco M.A., Law A., et al. Age and sex disparities in discussions about kidney transplantation in adults undergoing dialysis. J. Am. Geriatr. Soc. 2014;62(5):843-849. doi: 10.1111/jgs.12801.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies